Kim J. Rich
- Co-authors
- Alan R. BoobisDorothea SesardicD. S. DaviesBernard P. MurrayElizabeth A. MartinLewis L. SmithIan N.H. WhiteRobert J. Edwards
- Topics
- Pharmacogenetics and Drug Metabolism (10 papers)Carcinogens and Genotoxicity Assessment (7 papers)Drug Transport and Resistance Mechanisms (4 papers)
- Cited by
- PharmacologyCancer ResearchOncology
- Partner nations
- United KingdomFinlandSpain
In The Last Decade
Kim J. Rich
21 papers receiving 584 citations
Peers
Comparison fields: 5 of 75
- Pharmacology 281
- Oncology 175
- Molecular Biology 173
- Cancer Research 152
- Genetics 126
Countries citing papers authored by Kim J. Rich
This map shows the geographic impact of Kim J. Rich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim J. Rich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim J. Rich more than expected).
Fields of papers citing papers by Kim J. Rich
This network shows the impact of papers produced by Kim J. Rich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim J. Rich. The network helps show where Kim J. Rich may publish in the future.
Co-authorship network of co-authors of Kim J. Rich
This figure shows the co-authorship network connecting the top 25 collaborators of Kim J. Rich. A scholar is included among the top collaborators of Kim J. Rich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim J. Rich. Kim J. Rich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 16 | |
| 2 | 8 | |
| 3 | 70 | |
| 4 | 31 | |
| 5 | 3 | |
| 6 | 36 | |
| 7 | 74 | |
| 8 | 68 | |
| 9 | Enzymatic studies of the activation of heterocyclic food mutagens in man. | 14 |
| 10 | 12 | |
| 11 | 39 | |
| 12 | 96 | |
| 13 | 30 | |
| 14 | 1 | |
| 15 | 16 | |
| 16 | 51 | |
| 17 | 3 | |
| 18 | 3 | |
| 19 | 2 | |
| 20 | 1 |
About Kim J. Rich
Kim J. Rich is a scholar working on Pharmacology, Cancer Research and Pharmaceutical Science, having authored 21 papers that have together received 598 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (10 papers), Carcinogens and Genotoxicity Assessment (7 papers) and Drug Transport and Resistance Mechanisms (4 papers). The work is most often cited by research in Pharmacology (281 citations), Cancer Research (152 citations) and Oncology (175 citations). Kim J. Rich has collaborated with scholars based in United Kingdom, Finland and Spain. Frequent co-authors include Alan R. Boobis, Dorothea Sesardic, D. S. Davies, Bernard P. Murray, Elizabeth A. Martin, Lewis L. Smith, Ian N.H. White, Robert J. Edwards, Nigel J. Gooderham and D. S. Davies. Their work appears in journals such as Biochemical Journal, Biochemical Pharmacology and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.